Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Kovsies paint Bethlehem red!
2010-03-20

At the matric evening of the Secondary School Witteberg in Bethlehem were, from the left: Lebogang Motaung; Rozelle Venter; Prof. Jonathan Jansen, Rector and Vice-Chancellor of the UFS; Ernest Bezuidenhout; Donald Motaung; and Mr Rudi Buys, Dean of Student Affairs at the UFS.
Photo: Lynda Greyling


“The learners of the High School Witteberg are a wonderful example of the quality of students that we can expect as first years here at Kovsies next year,” Prof. Jonathan Jansen, Rector and Vice-Chancellor of the University of the Free State (UFS) said last night during a matric evening attended by 121 Grade 12 learners and their parents in a packed hall at the Secondary School Witteberg in Bethlehem.

Prof. Jansen and his wife Grace, as well as some of his colleagues were guests of honour at the event.

“We want to make a difference in the lives of our students at Kovsies and we want to ensure that our students make a difference in a divided world. This is why I want each Grade 12 learner who is here tonight to come and study at the UFS,” he told the learners and their parents.

“The UFS is going to become the university in the country that is serious about quality. We want to draw the best students. Quality entails hard work. It is about perseverance and your commitment towards your studies. That is the type of students we want.”

“My door is open to our students and they have access to come and talk to me. I also regularly sit at different places on the campus and then invite students to come and talk to me. I want our students to feel at home here.”

“I also want our students to feel free to talk about the use of language at the UFS. We love Afrikaans, English and Sesotho and are not going to fight about language. We are going to develop the use of Afrikaans so that more students can speak it – and this also goes for English and Sesotho.”

Prof. Jansen said that Kovsie students had to be balanced students. “Our students must also excel in sport, art, etc., because the development of students who are properly prepared for the workplace is what we strive for as a tertiary institution. Therefore we are going to establish an office that assists students in their career preparation and will offer students internships so that they can come into contact with leading firms in the commerce and industry sectors.”

“However, we shall also actively enhance our students’ learning experience and therefore we are going to send a group of first-year students overseas in the second semester this year to gain knowledge about issues like integration and collaboration.”

At the occasion Prof. Jansen announced that bursaries to study at the UFS in 2011 would be awarded to the two top Grade 12 learners of the school.

The Secondary School Witteberg had a 100% pass rate in the Grade 12 final examinations the past few years. In 2009 the school was seventh amongst the top 50 schools in the Free State Province. Five learners from the school were also amongst the top 20 learners in the Province last year. The school has already produced many top students for the UFS.

Mediaverklaring
Issued by: Lacea Loader
Director: Strategic Communication (acting)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
18 March 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept